Marisa Woutersen

Key details

Marisa Woutersen is a senior reporter for Life Sciences Intellectual Property Review and World IP Review. She largely covers intellectual property developments across the global life sciences sector, including pharmaceuticals, biotechnology, medtech, AI, M&A and regulation.

Since joining Newton Media in 2023, Marisa has reported across a wide range of topics, from the rise of generative AI and its impact on the creative industries to the crossover between intellectual property and sport, including issues affecting athletes, as well as global pharmaceutical disputes, vaccine technology, access to medicines and life sciences M&A.

She has reported live from court and regularly travels to international conferences, where she interviews lawyers, business leaders and other key industry figures.

Marisa holds a Master’s in International Law and a BA in Politics and International Relations from the University of Sussex, and is currently completing her NCTJ Diploma in Journalism.

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine search
Total results: 456

Articles by Marisa Woutersen

Chadha & Chadha hires former Remfry & Sagar patent partner
Careers
The Indian firm has added a partner who brings more than three decades of experience advising clients across the pharmaceuticals, life sciences, technology and manufacturing sectors.   4 June 2026
Heated LNP litigation puts Moderna and Acuitas in the spotlight
Americas
A district court has thrown out one challenge over the vaccine delivery technology, while a separate appeal could affect protections available to government contractors during national emergencies.   3 June 2026
UPC dispute resolution forum opens with ceremony in Slovenia
Europe
The court has officially opened its mediation and arbitration forum, with technology, life sciences and manufacturing companies expected to be among its earliest users—particularly in FRAND and licensing cases.   2 June 2026
Americas
A district jury has handed a J&J unit a clean sweep in its defence against a rival's heart pump patent claims, delivering a win under the seldom-invoked reverse doctrine of equivalents.   1 June 2026
Careers
The new hire brings nearly two decades of trial experience in complex disputes across patents, trademarks, copyright and confidential information, including landmark patent litigation before the UK Supreme Court.   1 June 2026
Americas
A US appeals court has thrown out a jury verdict against a South Korean medical device company, ruling that Insulet waited too long to bring its trade secret misappropriation claim.   29 May 2026
Careers
The Chicago firm has added a partner with experience across patent litigation and strategic counselling for clients in the pharma, biotech, and advanced technology sectors.   28 May 2026
Europe
A European court dismissed a challenge by a German generics manufacturer, confirming the validity of a patent covering a blood cancer combination therapy.   28 May 2026
Asia
China’s IP system is undergoing real change. Takeda’s IP head for the region explains what that looks like on the ground and why the old playbook no longer cuts it.   27 May 2026
Careers
A senior pharmaceutical lawyer, with experience across private practice and Big Pharma, joins the company after a decade-long tenure at Teva.   27 May 2026

Not finding what you're looking for, please try resetting your applied search and filters,
or try the
full site search.